Bruker Corporation (BRKR) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Billerica, MA, United States. The current CEO is Frank H. Laukien.
BRKR has IPO date of 2000-08-04, 11,396 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $6.01B.
Bruker Corporation is a leading global manufacturer of scientific instruments and analytical solutions serving life sciences, diagnostics, and industrial markets. The company operates through three primary segments: Bruker Scientific Instruments Life Science, Bruker Scientific Instruments NANO, and Bruker Energy & Supercon Technologies. Its product portfolio spans mass spectrometry systems, rapid pathogen identification platforms, molecular diagnostics kits, X-ray and electron microscopy tools, atomic force microscopy instrumentation, and advanced optical fluorescence systems. Bruker also develops superconducting materials and related devices for research and industrial applications. Headquartered in Billerica, Massachusetts, and incorporated in 1991, the company serves researchers, diagnostic laboratories, and industrial customers worldwide.
